Computed Tomography of Lymph Node Metastasis Before and After Radiation Therapy: Correlations With Residual Tumour
- PMID: 32871805
- PMCID: PMC7652507
- DOI: 10.21873/invivo.12093
Computed Tomography of Lymph Node Metastasis Before and After Radiation Therapy: Correlations With Residual Tumour
Abstract
Background: Computed tomography (CT) performed after radiation therapy (RT) is used to detect residual lymph node (LN) metastasis. Here, we investigated which LN parameters on pre- and post-RT CT images correlated with residual tumour in patients with head and neck cancer.
Patients and methods: We enrolled 23 patients who received RT. A total of 50 LNs were evaluated. Correlations between quantitative and qualitative findings and residual tumours were evaluated.
Results: The median patient age was 61 years. Thirty-one LNs were histologically confirmed to contain residual tumour. LNs with residual tumour had significantly longer short and long axes on post-RT CT images. A new finding of obscured margins after RT were significantly associated with the presence of residual tumour by univariate and multivariate analyses.
Conclusion: Comparison of qualitative, LN parameters on pre- and post-RT CT images may improve the detection of residual tumour in patients with suspected residual or recurrent LN metastasis.
Keywords: Computed tomography; head and neck cancer; histopathology; lymph node metastasis.
Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Conflict of interest statement
Drs. Ishibashi, Maebayashi, Nishimaki and Okada declare that they have no conflicts of interest in regard to this study.
Figures


Similar articles
-
Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck.J Clin Oncol. 2006 Mar 20;24(9):1421-7. doi: 10.1200/JCO.2005.04.6052. J Clin Oncol. 2006. PMID: 16549836
-
Diagnostic accuracy of F-18 FDG PET or PET/CT for detection of lymph node metastasis in clinically node negative head and neck cancer patients; A systematic review and meta-analysis.Am J Otolaryngol. 2019 Mar-Apr;40(2):297-305. doi: 10.1016/j.amjoto.2018.10.013. Epub 2018 Oct 23. Am J Otolaryngol. 2019. PMID: 30473166
-
The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):991-9. doi: 10.1016/j.ijrobp.2005.03.066. Epub 2005 Aug 15. Int J Radiat Oncol Biol Phys. 2005. PMID: 16099601
-
Intra-parotid lymph node metastasis in patients with non-cutaneous head and neck cancers: clinical and imaging features for differentiation from simultaneous parotid primary tumor.Acta Radiol. 2020 Dec;61(12):1628-1635. doi: 10.1177/0284185120908137. Epub 2020 Mar 5. Acta Radiol. 2020. PMID: 32138522
-
Guidelines for the delineation of nodal regions of the head and neck on axial computed tomography images.Tumori. 2002 Sep-Oct;88(5):355-60. doi: 10.1177/030089160208800501. Tumori. 2002. PMID: 12487550 Review.
Cited by
-
Development and validation of a nomogram for prediction of cervical lymph node metastasis in middle and lower thoracic esophageal squamous cell carcinoma.BMC Gastroenterol. 2022 Apr 3;22(1):163. doi: 10.1186/s12876-022-02243-8. BMC Gastroenterol. 2022. PMID: 35369868 Free PMC article.
References
-
- Simon C, Goepfert H, Rosenthal DI, Roberts D, El-Naggar A, Old M, Diaz EM Jr., Myers JN. Presence of malignant tumor cells in persistent neck disease after radiotherapy for advanced squamous cell carcinoma of the oropharynx is associated with poor survival. Eur Arch Otorhinolaryngol. 2006;263(4):313–318. doi: 10.1007/s00405-005-1016-0. - DOI - PubMed
-
- Adelstein DJ, Li Y, Adams GL, Wagner H Jr., Kish JA, Ensley JF, Schuller DE, Forastiere AA. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003;21(1):92–98. doi: 10.1200/JCO.2003.01.008. - DOI - PubMed
-
- Argiris A, Stenson KM, Brockstein BE, Mittal BB, Pelzer H, Kies MS, Jayaram P, Portugal L, Wenig BL, Rosen FR, Haraf DJ, Vokes EE. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck. 2004;26(5):447–455. doi: 10.1002/hed.10394. - DOI - PubMed
-
- Goguen LA, Posner MR, Tishler RB, Wirth LJ, Norris CM, Annino DJ, Sullivan CA, Li Y, Haddad RI. Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 2006;132(5):526–531. doi: 10.1001/archotol.132.5.526. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical